SHANGHAI, Jan 30 (Reuters) - Sciwind Biosciences' type 2 diabetes treatment Xianyida was approved for use in China, the company said on Friday, adding another participant to a hot sector in the ...
Numerous genetic studies have identified many risk variants for type 2 diabetes (T2D)—but which genes and proteins are ...
Ascletis Pharma has dosed the first participants in a US Phase II trial of ASC30, an oral small molecule glucagon-like ...
Recent advances in diabetes detection may help to identify risk earlier. In this article, MNT discusses recent studies that ...
The City of El Paso Department of Public Health (DPH) is offering free A1C testing to the community on “Take Charge Tuesdays” ...
An international study co-led by researchers from the University of Massachusetts Amherst and Helmholtz Munich in Germany has ...
Researchers have identified a protein pattern that, already at birth, looks markedly different in those who later go on to ...
Researchers have identified a protein pattern that, already at birth, looks markedly different in those who later go on to ...
The Indiana House reversed course on an effort to repeal “Hunter’s Law.” The 2007 law provides additional protection for kids ...
Is your backside trying to tell you something? New research suggests that the shape of the GM — not just the size — could be ...
Alexander Zverev booked a third straight Australian Open semifinal on Tuesday, outlasting Learner Tien 6-3, 6-7(5), 6-1, ...
Attendees got guidance about preventing diabetes, learning how to live with it, and how to maintain a health lifestyle.